ovestin 2 mg tabletter
aspen pharma trading ltd. - estriol - tabletter - 2 mg
vagifem 10 mikrogram vaginaltabletter
novo nordisk a/s - estradiolhemihydrat - vaginaltabletter - 10 mikrogram
estrogel 0,6 mg/g
besins healthcare ireland limited - estradiol - gel - 0,6 mg/g
senshio
shionogi b.v. - ospemifen - menopausen - køn hormoner og modulatorer af den genitale system, - senshio is indicated for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (vva) in post-menopausal women.
ercostrol 0,5 mg/dosis gel
orion corporation - estradiolhemihydrat - gel - 0,5 mg/dosis
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hypofysen og hypothalamus hormoner og analoger - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyom - hypofysiske og hypotalamiske hormoner og analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
letrozol "stada" 2,5 mg filmovertrukne tabletter
stada arzneimittel ag - letrozol - filmovertrukne tabletter - 2,5 mg
fareston
orion corporation - toremifen - bryst neoplasmer - endokrine terapi - første linjehormonbehandling af hormonafhængig metastatisk brystkræft hos postmenopausale patienter. fareston anbefales ikke til patienter med østrogen-receptor negative tumorer.
sogroya
novo nordisk a/s - somapacitan - vækst - hypofysiske og hypotalamiske hormoner og analoger - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).